• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
  • Reimbursement News
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Clinical trials

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19
  • Society Announcement
  • Reimbursement News

Specialty

All
  • Alle
  • YESCARTA
  • BEKEMV
  • NPLATE

Clinical trials

MRD status post-ASCT as a powerful predictor of PFS and OS in patients with multiple myeloma

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Restoring the delicate coagulation balance in haemophilia
  • Non-myeloablative haploidentical haematopoietic stem cell transplantation for adult patients with sickle cell disease: Current status and future perspectives
  • Unveiling cytokine profiles: HLH induced by the combination of cemiplimab and venetoclax
  • Clinical importance of screening for the neglected acquired von Willebrand syndrome in patients with myeloproliferative neoplasms: A case series
  • Journal scan
  • New haematology reimbursements in Belgium
Clinical trials

Novel CAR T-cell therapy GPRC5D shows promise in treatment of multiple myeloma

Read more
Clinical trials

Abnormal menstrual bleeding in women treated with anticoagulants for venous thromboembolism

Read more
Clinical trials

A+AVD superior to ABVD for the first-line treatment of newly diagnosed stage III or IV Hodgkin...

Read more
Clinical trials

Run To Kick benefits Belgian children with cancer more than ever before

Read more
Clinical trials

FDA approves pemigatinib for myeloid/lymphoid neoplasms patients with altered FGFR

Read more
Clinical trials

Adding elotuzumab to lenalidomide and dexamethasone does not improve PFS in patients with newl...

Read more
Clinical trials

LISO-CEL SHOWS SUPERIOR EFFICACY VS. STANDARD OF CARE AS SECOND-LINE TREATMENT FOR PRIMARY REF...

Read more
Clinical trials

Adding ibrutinib to bendamustine and rituximab prolongs progression-free survival in older pat...

Read more
Previous 5 6 7 8 9 10 11 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025